One actor accounts for a third of the market for painkillers
A new report shows that a single actor accounts for a third of the Danish market for pain medicines – a market that has shown very limited growth in 2011. The three largest companies account for almost 80 % of the market.
In 2011 the Danish market for pain killers reached a total value of DKK 535 million, which constitutes a limited growth of 1 % since 2010.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Painkillers increase the risk of blood clots
For abonnenter
